Home / BusinessBusinessBloombergBusinessBloomberg·Aug 4, 2026·1 min readNovo Nordisk Boosts Forecast on Soaring GLP-1 SalesNovo Nordisk A/S raised its forecast for the second time this year, citing higher expectations for its obesity and diabetes drug sales.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessThe PunchBusinessAug 4, 2026 · 1 minJUST IN: Tinubu meets Jim Ovia, NELFUND boss SawyerrThe PunchBusinessPhilippine Daily InquirerBusinessAug 4, 2026 · 1 minWB urges PH to widen tax base as spending needs growPhilippine Daily InquirerBusinessPhilippine Daily InquirerBusinessAug 4, 2026 · 1 minBIZ BUZZ: Gasmen meets the pressPhilippine Daily InquirerBusinessBloombergBusinessAug 4, 2026 · 1 minApple's India Business Hits a Major MilestoneBloomberg
BusinessThe PunchBusinessAug 4, 2026 · 1 minJUST IN: Tinubu meets Jim Ovia, NELFUND boss SawyerrThe Punch
BusinessPhilippine Daily InquirerBusinessAug 4, 2026 · 1 minWB urges PH to widen tax base as spending needs growPhilippine Daily Inquirer
BusinessPhilippine Daily InquirerBusinessAug 4, 2026 · 1 minBIZ BUZZ: Gasmen meets the pressPhilippine Daily Inquirer